On Wednesday, CVS announced strong second-quarter profits; DBV Technologies has submitted its Biologics License Application to the FDA for its treatment for peanut allergy; doctors, health organizations, and students are pushing for medical education to include climate change.
CVS’ deal with Aetna is beginning to pay off, according to the pharmacy chain’s second-quarter profit, which beat expectations. CVS on Wednesday reported $1.94 billion in profit. The company raised its full-year adjustment earnings forecast to $6.89 to $7.00 per share, up from $6.75 to $6.90. According to Reuters, the company is working to bring more healthcare services into its pharmacies and urge Aetna clients to take advantage of cheaper care for chronic conditions as its in-store clinics.
DBV Technologies has submitted its Biologics License Application to the FDA for Viaskin Peanut, its treatment for peanut allergy. The treatment, intended for children aged 4 to 11 years with the allergy, is designed to leverage the skin to activate the immune system and induce desensitization to allergens. In December 2018, DBV voluntarily withdrew its prior submission for the treatment based on additional data needed on manufacturing procedures and quality controls. Yesterday’s submission includes these data.
Backed by the American Medical Association, there is a movement from doctors, health organizations, and students for medical education to include climate change. The groups argue that physicians and other healthcare workers need to prepare for the risks association with rising global temperatures, reported The Wall Street Journal. Some schools have started to show support for the movement; The University of Minnesota’s medical, nursing, and pharmacy schools have added curriculum or tweaked existing courses to incorporate climate-related topics.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More